NAVERIS的动态

查看NAVERIS的组织主页

5,632 位关注者

ICYMI: We have added HPV-positive anal cancer surveillance testing to the list of cancer types that can be monitored by our innovative NavDx? blood test. Anal cancer is an especially challenging cancer to monitor for recurrence but utilizing routine NavDx surveillance testing can be an important part of post-treatment care. Learn more: https://lnkd.in/eUqmTyG5 #oncologynews #analcancer #healthcare

  • 该图片无替代文字

要查看或添加评论,请登录